Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Targeted Cancer Therapies & Biofluid Biopsies

Targeted Cancer Therapies & Biofluid Biopsies

Date: Thursday, 25 May 2017 - Friday, 26 May 2017
Location: Bengaluru

Keynote Speakers

Rajiv Raja

Rajiv Raja
Director, MedImmune/ AstraZeneca

Xinghua Victor Pan

Xinghua Victor Pan
Research Scientist, Yale University

Swapna Chaudhuri

Swapna Chaudhuri
Professor, Calcutta School of Tropical Medicine


After the last year's event on Biofluid Biopsies in Bengaluru, SELECTBIO brings to you an enhanced version of the same event on Cancer Diagnosis and Treatment. The event  has been entitled "Targeted Cancer Therapies and Biofluid Biopsies". 

The event aims to bring together different fraternities of scientists who are working towards Cancer diagnosis and selective treatment of cancer. Targetted cancer therapies include Cancer immunotherapy, Hormone therapy, ADC, Apoptosis inducers, Angiogenesis inhibitors, ST inhibitors and Gene therapy. The session on Biofluid biopsies will focus primarily on blood-based molecular biomarkers such as Circulating Tumor DNA (ctDNA) for developing biological fluid-based biopsies as well as Circulating Tumor Cells (CTCs) and Protein-based Circulating Biomarkers. 

This event is beneficial for the Scientists who are working or planning to work in the area of extracellular nucleic acids, extracellular vesicles, circulating cell free DNA, microRNA, Liquid biopsies etc. 

This conference will provide scientists and researchers with most up-to-date information & emerging trends in the area of Cancer Therapies and Biofluid Biopsies. Open discussions and break-out sessions on key thematic areas are sure to energize the participants in defining the Targetted Cancer Therapies and Circulating Biomarkers Landscape, especially in the Indian context.

Venue and Dates: Le Méridien Bangalore Hotel, Bengaluru, India on May 25-26, 2017

Sponsorship Options: Companies willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.

Call for Papers

If you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now!

Oral Presentation Submission Deadline: 30 April 2017

Agenda Topics

  • Antibodies and Antibody Drug Conjugates for Cancer Therapeutics
  • Cancer Immunotherapy
  • Circulating Cells & Nucleic Acids as Biomarkers
    • CTCs, cfDNA, exRNA, EVs
  • Current Targetted Cancer Therapies
    • Angiogenesis Inhibitors
    • Apoptosis Inducers
    • Hormone Therapies
    • Signal Transduction Inhibitors
  • Emerging Technology Platforms for Developing Biofluid-based Biopsies
  • Gene Therapy and Cancer Vaccines
  • Targetted Cancer Drug Delivery Systems

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager

Invited Confirmed Speakers

Hirak Basu, Associate Professor, University of Texas MD Anderson Cancer Center
Aditi Chatterjee, Faculty Scientist, Institute of Bioinformatics
Zijian Guo, Senior Scientist, Eurofins Lancaster Laboratories
Sunil J Advani, Associate Professor & Associate Division Director Clinical and Translational Research, University of California, San Diego
Olivier Pardo, Team Leader, Imperial College London
Winston Patrick Kuo, President, Predicine Holdings Ltd

Confirmed Speakers to date

Susanna T, Assistant Professor, Sri Devaraj Urs Medical College

Invited Speakers

Hikmet Budak, Professor, Sabanci University
Yan Chen, Sr. Technical Development Scientist & Group Leader, Genentech
Said Dermime, Senior Scientist & Director of Translational Cancer Research Facility, National Centre for Cancer Care and Research, HMC
Morganna Freeman, Associate Director, The Angeles Clinic and Research Institute
Abid Hamid Dar, Sr. Scientist, CSIR - Indian Institute of Integrative Medicine
Fred Hirsch, Professor, University of Colorado Cancer Center
Wen Jiang, Professor, Cardiff University
Shyamala Maheswaran, Associate Professor/Principal Investigator, Harvard Medical School
Marek Malecki, President, Phoenix Biomolecular Engineering Foundation
Mahitosh Mandal, Associate Professor, IIT Kharagpur
Abdelwahab Omri, Professor, Laurentian University
Adan Rios, Associate Professor, University of Texas Health Science Center
Barbara Seliger, Professor, Martin Luther University Halle-Wittenberg
Bernhard Stump, Scientist, Lonza Ltd
Shou-Ching Tang, Professor, Augusta University
Meghna Trivedi, Associate Professor, University of Houston College of Pharmacy
Timothy Yap, Clinician Scientist and Consultant Medical Oncologist, The Institute of Cancer Research
Huang-Ge Zhang, Professor, University of Louisville

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2017-05-25 00:00:002017-05-26 00:00:00Europe/LondonTargeted Cancer Therapies and Biofluid BiopsiesTargeted Cancer Therapies and Biofluid Biopsies in